| Jul 30 |
Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue Estimates
|
| Jul 30 |
Arvinas GAAP EPS of -$0.49 beats by $0.09, revenue of $76.5M beats by $5.98M
|
| Jul 30 |
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Jul 22 |
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
|
| Jul 17 |
Biotech Arvinas Stock Earns 82 RS Rating
|
| Jul 17 |
Arvinas (ARVN) Surges 9.2%: Is This an Indication of Further Gains?
|
| Jul 16 |
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
|
| Jul 15 |
Milestone Pharmaceuticals Refreshes Board of Directors
|
| Jul 12 |
Arvinas: Hugely Important Data Catalyst Upcoming - Success May Prove Elusive
|
| Jun 27 |
Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy Rating?
|
